Live from the NIH registry
Studies recruiting near Santa Rosa right now
Top 25 of 148 recruiting studies, sorted by proximity — each links to its official registry page
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Head and Neck Carcinoma, Adenoid Cystic Carcinoma
Phase 1, Phase 2
Interventional 242 participants sought
Providence Medical Foundation (site 209) — Santa Rosa, California (0.6 mi)
· Sponsor: VM Oncology, LLC
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Saint Helena Hospital — St. Helena, California (13.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Targeting Aging With a Ketone Ester for Function in Frailty
Frail Elderly, Aging
N/A
Interventional 180 participants sought
Buck Institute for Research on Aging — Novato, California (24.5 mi)
· Sponsor: Buck Institute for Research on Aging
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Saint Helena Hospital — St. Helena, California (13.4 mi)
· Sponsor: National Cancer Institute (NCI)
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: Janssen Research & Development, LLC
MISHA Post-Market Clinical Study
Osteo Arthritis Knee
N/A
Interventional 120 participants sought
Weiss Orthopedics — Sonoma, California (17.2 mi)
· Sponsor: Moximed
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: SWOG Cancer Research Network
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
Phase 1, Phase 2
Interventional 340 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: Inhibrx Biosciences, Inc
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: SWOG Cancer Research Network
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Sutter Pacific Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: NRG Oncology
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Adjustment Disorder
Phase 2
Interventional 100 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: Reunion Neuroscience Inc
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Glaucoma, Open-Angle, Ocular Hypertension
Phase 3
Interventional 168 participants sought
North Bay Eye Associates, Inc. — Petaluma, California (15.2 mi)
· Sponsor: Amneal Pharmaceuticals, LLC
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Phase 3
Interventional 2,500 participants sought
Anthos Investigative Site 9938 — Santa Rosa, California (0.6 mi)
· Sponsor: Anthos Therapeutics, Inc.
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Colorectal Neoplasms
Phase 3
Interventional 700 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: Janssen Research & Development, LLC
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Providence Medical Group - Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: Mirati Therapeutics Inc.
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Atrial Fibrillation (AF)
Phase 2
Interventional 1,200 participants sought
Northbay Clinical Research Center — Santa Rosa, California (0.6 mi)
· Sponsor: Regeneron Pharmaceuticals
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Prostate Cancer, Metastatic Castration Resistant Prostate Cancer
Phase 1
Interventional 174 participants sought
Providence Medical Group Oncology Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Tracking Results of Ablations to Combat AF Registry Generation 2
Atrial Fibrillation
N/A
Observational 10,000 participants sought
Adventist Heart Institute (St. Helena Hospital) — St. Helena, California (13.4 mi)
· Sponsor: AtriCure, Inc.
REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain
Lumbar Spinal Stenosis
N/A
Interventional 100 participants sought
Evolve Restorative Center — Santa Rosa, California (0.6 mi)
· Sponsor: Pacific Research Institute
Galleri® in the Medicare Population.
Cancer
N/A
Interventional 50,000 participants sought
Sutter Health Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: GRAIL, Inc.
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Metastatic Breast Cancer
Phase 3
Interventional 600 participants sought
Providence Medical Foundation - Santa Rosa, CA — Santa Rosa, California (0.6 mi)
· Sponsor: LeonaBio
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
Breast Cancer, Cognitive Impairments
N/A
Interventional 386 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: NRG Oncology
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology